Kingston, Jamaica. On Half-Way Tree Road in St Andrew, a short drive from this view, a new AI-enabled imaging centre opened in the first days of August 2026.
What happened: in the first days of August 2026, Oasis Imaging & MRI Centre opened a new facility on Half-Way Tree Road in St Andrew, Kingston, built around AI-enabled diagnostic imaging equipment. The technology cuts MRI scan times by 50 to 60 percent while still producing high-resolution images, and patients can get MRI results within 24 to 48 hours of a request, according to the Jamaica Gleaner's coverage of the opening. Health Minister Dr Christopher Tufton attended the launch. It is a genuine technical upgrade for Jamaican healthcare. It is also, so far, available in exactly one parish, at one private clinic, and it does nothing about the specialist shortages that create Jamaica's longest diagnostic delays elsewhere in the system.
What Opened on Half-Way Tree Road
Oasis is not new to Jamaica. The company was founded in 2014 and built its reputation out of Spanish Town before expanding into Kingston with a facility that offers MRI, CT scans, digital X-rays, ultrasound, mammography, and general imaging services. What makes the new centre different is the equipment behind the machines: AI-enabled diagnostic imaging systems that process scans faster without sacrificing the resolution radiologists need to spot small or ambiguous findings. The centre also offers specialised prostate and breast imaging, two areas where earlier detection has an outsized effect on treatment outcomes.
Oasis CEO Dr Ravi Prakash Sangappa put the reasoning plainly at the launch: the company invested in new AI-enabled equipment because high-quality images help radiologists make more accurate diagnoses, not simply faster ones. Indian High Commissioner Mayank Joshi, whose government supported the equipment rollout, called it a timely contribution that strengthens Jamaica's diagnostic capabilities. Dr Tufton, never one to undersell a ribbon-cutting, praised the centre's "service with compassion, service with care."
Fifty to sixty percent is not a marketing rounding error. For a patient whose doctor is trying to rule out something serious, or confirm it early enough to matter, that difference between a next-day result and a two-week wait can be the entire ballgame. This is real progress, and it deserves to be treated as such rather than waved off as one more press release from one more private clinic.
Why Speed Alone Doesn't Close Jamaica's Diagnostic Gap
Here is the part the ribbon-cutting quotes tend to skip. A faster scanner solves exactly one link in a much longer chain, and it happens not to be the link that is currently breaking under the most strain.
The Cytologist Bottleneck
Jamaica has a national shortage of cytologists, the specialists trained to examine cell samples for early signs of cancer. Reporting by the Jamaica Gleaner in July 2025 documented Pap smear results taking anywhere from three months to a full year to come back to patients, against a typical turnaround of about four weeks. That delay has nothing to do with how fast an MRI machine can spin. It has everything to do with how few trained people Jamaica has reading slides, and how many samples are stacked up waiting for them. A woman who gets her Pap smear done on time can still wait most of a year to find out what it says. No imaging upgrade touches that queue.
What Late Presentation Looks Like in the Numbers
The clearest evidence of what these delays cost sits in a peer-reviewed study published in the World Journal of Oncology, which examined the stage, grade, and molecular subtype of breast cancer cases across Jamaica. Fifty percent of patients in the registry had axillary lymph node metastases at the time of presentation, well above the 26 to 33 percent typically reported in United States cancer databases. Roughly 40 percent presented with Stage III disease overall, and that figure rose to 51 percent among patients under 50, the group least likely to be routinely screened in the first place. Jamaican patients in the study were, on average, younger than their American counterparts at diagnosis, yet arrived with more advanced disease. That is not a story about biology being crueller in Jamaica. It is a story about time lost between a first symptom and a confirmed diagnosis.
"Di machine quick now, but mi still a wait pon di actual result from di lab." A Kingston-based general practitioner, describing the gap between imaging turnaround and pathology turnaround for her own patients
One Private Clinic Does Not Make a National Fix
None of this is a knock on Oasis, which has done something worth doing and done it well. The issue is distribution. Jamaica has tried to widen access to diagnostic imaging before, most notably when the Ministry of Health and Wellness signed framework agreements with ten radiology providers under its Enhancing Healthcare Services Delivery Project, aimed squarely at reducing wait times and overcrowding in the public system. That model, public funding routed through private diagnostic capacity, already exists in Jamaica. What has not yet happened is that same model extending AI-enabled equipment specifically, rather than conventional scanners, into public-facing care. As of this article's publication, no public hospital had announced AI-enabled MRI or CT equipment at the scale now sitting on Half-Way Tree Road.
That gap between what exists in one Kingston clinic and what is reachable from a public health centre in Westmoreland or St Mary is the real Jamaican healthcare story of 2026, and it is bigger than any single ribbon-cutting. Jamaica's internet penetration now sits at roughly 85 percent nationally, according to reporting from the Joint SDG Fund on AI governance in Jamaica, which means the connectivity needed to support telemedicine and remote diagnostic review already reaches most of the country. The infrastructure argument for extending AI-assisted screening beyond Kingston's private clinics is not really an infrastructure argument anymore. It is a procurement and funding argument.
AI-enabled diagnostic imaging equipment of the kind now installed at the new Oasis centre in Kingston. The technology exists. Reaching the public system with it is the open question.
What Comes After the Scanner
Faster imaging and faster pathology are two different problems with two different fixes, and Jamaica needs both worked on at once rather than one celebrated while the other waits its turn. AI has a genuine role to play on the pathology and cytology side too: AI-assisted screening tools already used elsewhere in the world can flag likely abnormal cells for a human specialist to confirm, letting a small cytologist workforce process a larger volume of slides without cutting corners on accuracy. That is a different application of the same underlying technology now speeding up MRI scans at Oasis, aimed at the queue that is actually longest.
Telemedicine matters here too, and not as an abstraction. A radiologist in Kingston reviewing a scan captured in Mandeville or Savanna-la-Mar removes the need for a patient to travel for a specialist read, provided the connectivity and equipment on both ends can support it. Jamaica's growing AI research base, including applied work from firms like StarApple Analytics, is exactly the kind of capacity that turns a good idea like AI-assisted rural triage into something a hospital can actually deploy, rather than a line in a policy document.
The Regional Pieces Already in Place
Jamaica is not building any of this from a blank page. AI Jamaica has spent years building public AI literacy at the community level, the kind of groundwork that makes patients and general practitioners alike more comfortable trusting an AI-assisted diagnosis rather than treating it as a black box. On the talent side, closing Jamaica's cytologist and radiology specialist shortage over the next decade is exactly the kind of long-horizon problem The Genius Project was built for, training young Jamaicans in AI and STEM skills years before they ever sit a medical school entrance exam. Neither replaces a funded national procurement plan for AI-enabled diagnostic equipment. Both make that plan more likely to work once it exists.
The honest read on the Oasis launch is that it proves the technology works in a Jamaican clinical setting, at Jamaican patient volumes, under Jamaican operating conditions. That is not a small thing. It removes the "would this even work here" question from the table entirely. What remains is a distribution and workforce question, and those tend to be slower and less photogenic than a ribbon-cutting, even when they matter more.
Jamaica now has proof that AI-enabled imaging cuts wait times by more than half in a real clinic on Half-Way Tree Road. The next test is whether that proof turns into a plan that reaches beyond it.